BioNexus Gene Lab BGLC
NASDAQ BGLC
$1.59 +0.00 (+0.22%)
As of: Aug 21, 2026 · 3:59 PM EDT

BioNexus Gene Lab (BGLC) Non Operating Investment Income (2024 - 2025)

BioNexus Gene Lab (BGLC) posted Non Operating Investment Income of -$28256.0 for Q4 2025, down 219.01% sequentially from $23742.0 in Q2 2025, and up 83.72% YoY from -$15379.6 in Q4 2024.

BioNexus Gene Lab (BGLC) Non Operating Investment Income (2024 - 2025) Analysis & Trends

BioNexus Gene Lab has reported Non Operating Investment Income for 2 years, with the latest figure at -$28256.0 in Q4 2025.

  • Quarterly Non Operating Investment Income rose 83.72% year-over-year to -$28256.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$4514.0 (up 58.18% YoY) and the FY2024 annual result came in at $69476.0, down 77.34% from the prior year.
  • Non Operating Investment Income retreated to -$28256.0 in Q4 2025 per BGLC's latest filing, from $23742.0 in the prior quarter.
  • Over five years, Non Operating Investment Income peaked at $88532.0 in Q2 2024 and troughed at -$173607.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Linde 225.67 Bn 220.77 Bn 4.43 Bn -
2 Sherwin Williams 84.74 Bn 84.44 Bn 3.34 Bn -
3 Ecolab 78.90 Bn 73.77 Bn 1.95 Bn -
4 Air Products & Chemicals 68.19 Bn 67.21 Bn 1.04 Bn -
5 Ppg Industries 25.36 Bn 23.77 Bn 1.81 Bn -
6 Chemical & Mining Co Of Chile 23.48 Bn 19.61 Bn 778.60 Mn -
7 LyondellBasell Industries 21.91 Bn 19.28 Bn 2.04 Bn -
8 International Flavors & Fragrances 21.51 Bn 20.94 Bn 853.00 Mn -
9 DuPont de Nemours 18.83 Bn 17.09 Bn 639.00 Mn -
10 BioNexus Gene Lab 2.28 Mn -1.25 Mn 12,982.00 -

Historic Data

Download Data
DateValue
Dec 31, 2025 -28,256.00
Dec 31, 2025 -28,256.00
Jun 30, 2025 23,742.00
Jun 30, 2025 23,742.00
Mar 31, 2025 4,514.00
Mar 31, 2025 4,514.00
Dec 31, 2024 -173,607.00
Dec 31, 2024 -173,607.00
Sep 30, 2024 69,766.00
Sep 30, 2024 69,766.00
Jun 30, 2024 88,532.00
Jun 30, 2024 88,532.00
Mar 31, 2024 84,785.00
Mar 31, 2024 84,785.00